Therapeutic targets in airway inflammation /
| Other Authors: | , |
|---|---|
| Format: | Book |
| Language: | English |
| Published: |
New York :
Marcel Dekker,
[2003]
|
| Series: | Lung biology in health and disease ;
v. 177. |
| Subjects: |
Table of Contents:
- Pathophysiology of airway inflammation in asthma
- Primary human lung cells in the evaluation of airway inflammation
- Airway pH homeostasis in asthma and other inflammatory lung diseases
- Monitoring of exhaled breath to assess airway inflammation in asthma
- The modulatory effects of carbon monoxide on the inflammatory response
- Reactive nitrogen species and tyrosine nitration in airway inflammation
- S-nitrosothiols in lung inflammation
- Contribution of nitric oxide synthase isoforms to allergen-induced airway hyperresponsiveness and inflammation : lessons from murine models
- Molecular mechanisms of increased nitric oxide in airway inflammation
- Regulation of nitric oxide synthesis by inducible nitric oxide synthase
- Novel strategies for selective inhibition of inducible nitric oxide synthase
- Leukocyte recruitment in allergic pulmonary inflammation
- Neutrophil emigration in the lungs
- Dendritic cells
- Roles of mast cells in airway hyperreactivity, inflammation and remodeling, and immunoregulation in asthma
- Mast cell exocytosis in airway inflammation
- Mast cell proteases
- Peroxidases and asthma
- Chemokines in allergic airway inflammation
- Role of the eotaxin subfamily of chemokines in allergic eosinophilic inflammation
- Interleukin-4 and interleukin-13 in human and experimental asthma
- Interleukin-5 and eosinophils as therapeutic targets for the treatment of asthma
- Modulating the interleukin-5 response in asthma
- The role of interleukin-9 in allergic inflammation of asthma
- Epithelial production of IL-12 p80 during viral infection and asthma supports an altered paradigm for airway inflammation
- Interleukin-16 and airway hyperresponsiveness in asthma
- Modulation of the allergic response : the role of IL-18
- Inhibition of cytokine signaling
- Eicosanoids as mediators and therapeutic targets in airway inflammation
- Nitric oxide, reactive nitrogen species, and lipid mediator generation in the lung
- Adenosine signaling and lung inflammation
- Complement factor 5 in asthma
- Complement anaphylatoxin receptors in asthma
- Inflammatory and structural changes in airway remodeling of asthma
- The role of proteases in airway remodeling
- Airway smooth muscle : an immunomodulatory cell?
- Cellular trafficking of beta-₂-adrenergic receptors
- Genetic targets in asthma
- Application of pharmacogenetics to the therapeutics of asthma
- DNA-based immunotherapy for asthma
- Allergen Immunotherapy : therapeutic vaccines for allergic diseases
- Peptide-based therapy for asthma
- Reducing IgE levels as a strategy for the treatment of asthma
- Strategies to reduce excessive mucus secretion in airway inflammation